World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
122
Citations
55744
World Ranking
3474
National Ranking
1909

Paul H. Sugarbaker publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Paul H. Sugarbaker sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 827 publications — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Paul H. Sugarbaker D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Paul H. Sugarbaker sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 122 D-Index — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Paul H. Sugarbaker is affiliated with the MedStar Washington Hospital Center in the United States. Their research primarily focuses on medical and surgical oncology, with a specialized emphasis on intraperitoneal and appendiceal malignancies, appendicitis diagnosis and management, and ovarian cancer diagnosis and treatment.

Their work spans several subfields within medicine, including surgery, reproductive medicine, emergency medicine, pulmonary and respiratory medicine, and obstetrics and gynecology. The most prominent subdiscipline in their publication record is surgery, reflecting the clinical and procedural nature of their studies.

Frequent publication venues for their research include:

  • Journal of Gastrointestinal Oncology
  • European Journal of Surgical Oncology
  • Journal of Surgical Oncology
  • International Journal of Surgery Case Reports
  • Surgical Oncology

Among the main topics covered in their work are:

  • Intraperitoneal and Appendiceal Malignancies
  • Appendicitis Diagnosis and Management
  • Ovarian cancer diagnosis and treatment
  • Occupational and environmental lung diseases
  • Neuroendocrine Tumor Research Advances
  • Uterine Myomas and Treatments
  • Hernia repair and management

Some of the recent papers they have contributed to include:

  • "Appendiceal tumours and pseudomyxoma peritonei: Literature review with PSOGI/EURACAN clinical practice guidelines for diagnosis and treatment" (2020), published in European Journal of Surgical Oncology
  • "The Role of Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery" (2021), published in JAMA Surgery
  • "Peritoneal mesothelioma: PSOGI/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up" (2020), published in European Journal of Surgical Oncology
  • "Colorectal cancer cells from patients treated with FOLFOX or CAPOX are resistant to oxaliplatin" (2020), published in European Journal of Surgical Oncology
  • "Long term survival in patients with peritoneal metastasised gastric cancer treated with cytoreductive surgery and HIPEC: A multi-institutional cohort from PSOGI" (2020), published in European Journal of Surgical Oncology

The scientist frequently collaborates with a group of coauthors, including David Chang, Kurt Van der Speeten, Olivier Gléhen, David L. Morris, and Beate Rau, who have contributed to a significant number of joint publications.

Best Publications

  • Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis

    Pierre Jacquet;Paul H. Sugarbaker

  • The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy.

    S A Rosenberg;J Tepper;E Glatstein;J Costa

  • Cytoreductive Surgery Combined With Perioperative Intraperitoneal Chemotherapy for the Management of Peritoneal Carcinomatosis From Colorectal Cancer: A Multi-Institutional Study

    O. Glehen;F. Kwiatkowski;P.H. Sugarbaker;D. Elias

  • Early- and Long-Term Outcome Data of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

    Terence C. Chua;Brendan J. Moran;Paul H. Sugarbaker;Edward A. Levine

  • Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei".

    Brigite M. Ronnett;Christopher M. Zahn;Robert J. Kurman;Mary E. Kass

  • A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases.

    Alfred E. Chang;Philip D. Schneider;Paul H. Sugarbaker;Colleen Simpson

  • A Consensus for Classification and Pathologic Reporting of Pseudomyxoma Peritonei and Associated Appendiceal Neoplasia: The Results of the Peritoneal Surface Oncology Group International (PSOGI) Modified Delphi Process.

    Norman J. Carr;Thomas D. Cecil;Faheez Mohamed;Leslie H. Sobin

  • Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional Experience

    Tristan D. Yan;Marcello Deraco;Dario Baratti;Shigeki Kusamura

  • Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy.

    Paul H. Sugarbaker;David Chang

  • Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of long-term survivors.

    Kevin S. Hughes;Rebecca B. Rosenstein;Sate Songhorabodi;Martin A. Adson

  • Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Surface Malignancies of Colonic Origin: A Consensus Statement

    J. Esquivel;R. Sticca;P. Sugarbaker;E. Levine

  • Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis

    Paul H. Sugarbaker

  • Morbidity and Mortality Analysis of 200 Treatments With Cytoreductive Surgery and Hyperthermic Intraoperative Intraperitoneal Chemotherapy Using the Coliseum Technique

    Arvil D. Stephens;Robert Alderman;David Chang;Gary D. Edwards

  • Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis.

    Brigitte M. Ronnett;Hui Yan;Robert J. Kurman;Barry M. Shmookler

  • A Systematic Review and Meta-analysis of the Randomized Controlled Trials on Adjuvant Intraperitoneal Chemotherapy for Resectable Gastric Cancer

    Tristan D. Yan;Tristan D. Yan;Deborah Black;Paul H. Sugarbaker;Jacqui Zhu

  • Systematic Review on the Efficacy of Cytoreductive Surgery Combined With Perioperative Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis From Colorectal Carcinoma

    Tristan D. Yan;Deborah Black;Renaldo Savady;Paul H. Sugarbaker

  • Analysis of Prognostic Factors in Seventy Patients Having a Complete Cytoreduction plus Perioperative Intraperitoneal Chemotherapy for Carcinomatosis from Colorectal Cancer

    Rodrigo Gomes da Silva;Paul H. Sugarbaker

  • Hepatic tumors: comparison of CT during arterial portography, delayed CT, and MR imaging for preoperative evaluation.

    R C Nelson;J L Chezmar;P H Sugarbaker;M E Bernardino

  • Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer

    Rhonda L Harmon;Paul H Sugarbaker

  • Erratum: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: A consensus statement (Annals of Surgical Oncology 14 (128-133)DOI: 10.1245/s10434-006-9185-7)

    J. Esquivel;R. Sticca;P. Sugarbaker;E. Levine

Frequent Co-Authors

Tristan D. Yan
Tristan D. Yan Royal Prince Alfred Hospital
David L. Morris
David L. Morris University of New South Wales
Edward A. Levine
Edward A. Levine Wake Forest University
David L. Bartlett
David L. Bartlett University of Pittsburgh
David W. Chang
David W. Chang University of Chicago
Brendan J. Moran
Brendan J. Moran University of New South Wales
Dominique Elias
Dominique Elias Institut Gustave Roussy
H. Richard Alexander
H. Richard Alexander Rutgers, The State University of New Jersey
Hedy L. Kindler
Hedy L. Kindler University of Chicago
Andrew M. Lowy
Andrew M. Lowy University of California, San Diego

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in medicine, there are many online pathways to advance your health care career. If you're already an RN, exploring an rn to bsn online with no clinicals program can help you earn your Bachelor of Science in Nursing quickly and conveniently—often without any in-person clinical hours.

Aspiring nurse practitioners or those with higher goals may be curious about doctoral programs. Options such as the shortest online dnp program and shortest dnp program allow nurses to achieve a Doctor of Nursing Practice degree in less time and with flexible online study.

For those beginning their healthcare journey, fast-track and fully online programs like a 9 month lpn program provide a rapid route to becoming a Licensed Practical Nurse. Each of these options offers a unique balance of speed, flexibility, and career advancement for students who want to pursue medical careers in the USA through online education.

Best Scientists Citing Paul H. Sugarbaker

Trending Scientists

Recently Published Articles